Congress Wealth Management LLC DE Decreases Stock Holdings in STERIS plc (NYSE:STE)

Congress Wealth Management LLC DE reduced its position in shares of STERIS plc (NYSE:STE) by 5.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 54,145 shares of the medical equipment provider’s stock after selling 2,879 shares during the period. Congress Wealth Management LLC DE owned 0.05% of STERIS worth $11,130,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. KLP Kapitalforvaltning AS purchased a new stake in STERIS in the 4th quarter worth approximately $6,434,000. Knights of Columbus Asset Advisors LLC raised its holdings in shares of STERIS by 4.7% during the fourth quarter. Knights of Columbus Asset Advisors LLC now owns 12,417 shares of the medical equipment provider’s stock valued at $2,552,000 after acquiring an additional 553 shares in the last quarter. Sei Investments Co. lifted its stake in STERIS by 7.4% in the fourth quarter. Sei Investments Co. now owns 142,193 shares of the medical equipment provider’s stock worth $29,229,000 after acquiring an additional 9,777 shares during the period. American Century Companies Inc. boosted its holdings in STERIS by 10.6% in the fourth quarter. American Century Companies Inc. now owns 369,698 shares of the medical equipment provider’s stock valued at $75,995,000 after acquiring an additional 35,424 shares in the last quarter. Finally, Mizuho Securities USA LLC raised its holdings in STERIS by 46.3% in the 4th quarter. Mizuho Securities USA LLC now owns 9,355 shares of the medical equipment provider’s stock worth $1,923,000 after purchasing an additional 2,960 shares in the last quarter. 94.69% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Piper Sandler lifted their target price on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Stephens reaffirmed an “overweight” rating and set a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Finally, JMP Securities restated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research note on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, STERIS has an average rating of “Moderate Buy” and a consensus price target of $258.75.

STERIS Trading Up 1.2 %

NYSE:STE opened at $223.03 on Tuesday. The firm has a market capitalization of $21.91 billion, a P/E ratio of 47.35 and a beta of 0.92. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. STERIS plc has a one year low of $197.82 and a one year high of $248.24. The company’s 50-day simple moving average is $221.34 and its 200 day simple moving average is $221.73.

STERIS (NYSE:STE) last posted its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were issued a dividend of $0.57 per share. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.02%. STERIS’s payout ratio is presently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.